PL372862A1 - Epitopy limfocytu T w erytropoetynie - Google Patents

Epitopy limfocytu T w erytropoetynie

Info

Publication number: PL372862A1
Authority: PL; Poland
Prior art keywords: erythropoietin; cell epitopes; epo; epitopes; cells
Prior art date: 2002-08-09

Application number

PL03372862A

Other languages

English (en)

Inventor

Matthew Baker

Francis J. Carr

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-09

Filing date

2003-08-07

Publication date

2005-08-08

2003-08-07 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2005-08-08 Publication of PL372862A1 publication Critical patent/PL372862A1/pl

Links

210000001744 T-lymphocyte Anatomy 0.000 title abstract 3
102000003951 Erythropoietin Human genes 0.000 title 1
108090000394 Erythropoietin Proteins 0.000 title 1
229940105423 erythropoietin Drugs 0.000 title 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
108010092408 Eosinophil Peroxidase Proteins 0.000 abstract 1
101000987586 Homo sapiens Eosinophil peroxidase Proteins 0.000 abstract 1
102000044890 human EPO Human genes 0.000 abstract 1
230000005847 immunogenicity Effects 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Hematology (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Peptides Or Proteins (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PL03372862A 2002-08-09 2003-08-07 Epitopy limfocytu T w erytropoetynie PL372862A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02017914		2002-08-09

Publications (1)

Publication Number	Publication Date
PL372862A1 true PL372862A1 (pl)	2005-08-08

Family

ID=31896824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL03372862A PL372862A1 (pl)	2002-08-09	2003-08-07	Epitopy limfocytu T w erytropoetynie

Country Status (16)

Country	Link
US (1)	US20060035322A1 (pl)
EP (1)	EP1527094B1 (pl)
JP (1)	JP2006515161A (pl)
KR (1)	KR20060003853A (pl)
CN (1)	CN1675242A (pl)
AT (1)	ATE401344T1 (pl)
AU (1)	AU2003263201A1 (pl)
BR (1)	BR0313135A (pl)
CA (1)	CA2494963A1 (pl)
DE (1)	DE60322225D1 (pl)
ES (1)	ES2310684T3 (pl)
MX (1)	MXPA05001452A (pl)
PL (1)	PL372862A1 (pl)
RU (1)	RU2005106841A (pl)
WO (1)	WO2004018515A2 (pl)
ZA (1)	ZA200501974B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE60332358D1 (de) *	2002-09-09	2010-06-10	Hanall Pharmaceutical Co Ltd	Protease-resistente modifizierte interferon alpha polypeptide
US20060073563A1 (en) *	2004-09-02	2006-04-06	Xencor, Inc.	Erythropoietin derivatives with altered immunogenicity
US9345745B2 (en)	2005-04-29	2016-05-24	Bo Wang	Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
WO2007052154A2 (en) *	2005-04-29	2007-05-10	University Of Medicine And Dentistry Of New Jersey	Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators
EP2385061A3 (en) *	2005-05-10	2012-02-22	Neoloch Aps	Neuritogenic peptides
WO2008065372A2 (en)	2006-11-28	2008-06-05	Nautilus Biotech, S.A.	Modified erythropoietin polypeptides and uses thereof for treatment
AU2008279550B2 (en) *	2007-06-21	2012-08-09	Angelica Therapeutics, Inc.	Modified toxins
WO2009110944A1 (en) *	2008-02-29	2009-09-11	Angelica Therapeutics, Inc.	Modified toxins
EP2968450A4 (en)	2013-03-15	2016-10-26	Angelica Therapeutics Inc	MODIFIED TOXINS
CA2918223A1 (en) *	2013-07-17	2015-01-22	Araim Pharmaceuticals, Inc.	Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
CN106554395B (zh) *	2015-09-30	2019-08-16	天津药物研究院有限公司	一种长效促红细胞生成素模拟肽及其制备方法和应用
AR113091A1 (es) *	2018-09-27	2020-01-22	Univ Nacional Del Litoral	Eritropoyetina humana modificada
CA3192758A1 (en) *	2020-09-04	2022-03-10	Dompe' Farmaceutici Spa	Peptides endowed with angiogenic activity
EP3964225A1 (en) *	2020-09-04	2022-03-09	Dompe' Farmaceutici S.P.A.	Peptides endowed with angiogenic activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4954437A (en) *	1986-09-15	1990-09-04	Integrated Genetics, Inc.	Cell encoding recombinant human erythropoietin
US4835260A (en) *	1987-03-20	1989-05-30	Genetics Institute, Inc.	Erythropoietin composition
DE3924746A1 (de) *	1989-07-26	1991-01-31	Behringwerke Ag	Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
NZ244778A (en) *	1991-10-21	1994-03-25	Ortho Pharma Corp	Peg imidates and protein derivatives thereof
AU776910B2 (en) *	1998-12-08	2004-09-23	Merck Patent Gesellschaft Mit Beschrankter Haftung	Modifying protein immunogenicity
CA2288341C (en) *	1998-12-17	2005-01-04	Pfizer Products Inc.	Erythropoietin in the treatment of domestic and livestock animals for anemia
KR20030057529A (ko) *	2000-09-08	2003-07-04	그리폰 테라퓨틱스, 인코포레이티드	합성 적혈구생성 자극 단백질
US20040063917A1 (en) *	2001-02-06	2004-04-01	Carr Francis J.	Modified erythropoietin (epo) with reduced immunogenicity
WO2002069232A2 (en) *	2001-02-19	2002-09-06	Merck Patent Gmbh	Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity

2003
- 2003-08-07 PL PL03372862A patent/PL372862A1/pl not_active Application Discontinuation
- 2003-08-07 CA CA002494963A patent/CA2494963A1/en not_active Abandoned
- 2003-08-07 ES ES03792268T patent/ES2310684T3/es not_active Expired - Lifetime
- 2003-08-07 KR KR1020057002338A patent/KR20060003853A/ko not_active Withdrawn
- 2003-08-07 AU AU2003263201A patent/AU2003263201A1/en not_active Abandoned
- 2003-08-07 CN CNA038189690A patent/CN1675242A/zh active Pending
- 2003-08-07 JP JP2004530097A patent/JP2006515161A/ja not_active Withdrawn
- 2003-08-07 DE DE60322225T patent/DE60322225D1/de not_active Expired - Lifetime
- 2003-08-07 MX MXPA05001452A patent/MXPA05001452A/es not_active Application Discontinuation
- 2003-08-07 US US10/522,297 patent/US20060035322A1/en not_active Abandoned
- 2003-08-07 AT AT03792268T patent/ATE401344T1/de not_active IP Right Cessation
- 2003-08-07 EP EP03792268A patent/EP1527094B1/en not_active Expired - Lifetime
- 2003-08-07 BR BR0313135-1A patent/BR0313135A/pt not_active IP Right Cessation
- 2003-08-07 WO PCT/EP2003/008725 patent/WO2004018515A2/en not_active Ceased
- 2003-08-07 RU RU2005106841/13A patent/RU2005106841A/ru not_active Application Discontinuation
2006
- 2006-01-10 ZA ZA200501974A patent/ZA200501974B/en unknown

Also Published As

Publication number	Publication date
JP2006515161A (ja)	2006-05-25
CA2494963A1 (en)	2004-03-04
EP1527094A2 (en)	2005-05-04
ATE401344T1 (de)	2008-08-15
WO2004018515A2 (en)	2004-03-04
RU2005106841A (ru)	2005-10-27
BR0313135A (pt)	2005-07-05
US20060035322A1 (en)	2006-02-16
EP1527094B1 (en)	2008-07-16
WO2004018515A3 (en)	2004-06-03
ES2310684T3 (es)	2009-01-16
MXPA05001452A (es)	2005-06-06
ZA200501974B (en)	2006-03-29
KR20060003853A (ko)	2006-01-11
AU2003263201A1 (en)	2004-03-11
DE60322225D1 (en)	2008-08-28
CN1675242A (zh)	2005-09-28

Legal Events

Date	Code	Title	Description
2011-06-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
DE60322225D1 (en)	2008-08-28	T-zellen-epitope in erythropoietin
IL267186A (en)	2019-08-29	Epitopes of regulated T cells, preparations and uses
AU2002302255A1 (en)	2002-12-09	Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
MXPA02005576A (es)	2002-12-13	Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
PL366826A1 (pl)	2005-02-07	Zmniejszanie immunogenności białek fuzyjnych
MX336807B (es)	2016-02-02	Composiciones y metodos para producir una composicion.
MX338940B (es)	2016-05-06	Identificacion de epitopos ige novedosos.
EP1609107A4 (en)	2006-08-30	METHOD FOR IDENTIFYING OPTIMAL PEPTIDE PITOPARIANTS
DE60320009D1 (de)	2008-05-08	Transplant-Akzeptanz induzierende Zellen monocytären ursprungs, sowie deren Herstellung und Verwendung
BRPI0413924A (pt)	2006-10-24	composições antiperspirantes estabilizadas contendo produtos de soja
IL196900A (en)	2015-03-31	Autologous T cell vaccine compositions
ATE412671T1 (de)	2008-11-15	Modifizierter faktor viii
EP1344827A3 (en)	2003-10-15	Antifreeze proteins from basidiomycetes
WO2004039834A3 (en)	2004-08-26	Recombinant protein variants
WO2005120564A3 (en)	2007-11-15	Vaccine compositions and methods
WO2004018684A3 (en)	2004-08-26	T-cell epitopes in staphylococcal enterotoxin b
WO2004058188A3 (en)	2005-02-10	Vaccine compositions and methods
EP1480998A4 (en)	2005-06-08	INTERMEDIATES AND METHODS FOR MAKING OXYTOCIN ANALOGUES HEPTAPEPTIDE
UA100692C2 (ru)	2013-01-25	Днк-плазмиды, имеющие повышенную экспрессию и стабильность
AU2003218337A1 (en)	2003-10-27	Growth hormone secretagogues
WO2007081301A3 (en)	2010-05-06	Methods and compositions related to the identification of a novel il-12 inducing protein isolated from toxoplasma gondii
UA87709C2 (ru)	2009-08-10	Способ очищения фолликулостимулирующего гормона
MY142798A (en)	2010-12-31	Methods for preventing glyconoylation of proteins
WO2022109168A3 (en)	2022-07-21	Novel var2csa immunogens and methods of use thereof
GB9919732D0 (en)	1999-10-20	Trehalose producing cells as vaccines